A-shares' three major indices showed mixed performance, while the GPU sector experienced a strong upward trend. Multiple stocks in the pharmaceutical sector surged by the daily limit.
On the morning of April 15, the three major A-share indices opened collectively higher. The ChiNext Index hit a new ten-year high during the session before undergoing a period of volatile adjustment. By the midday close, the Shanghai Composite Index had risen by 0.37%, while the Shenzhen Component Index fell by 0.25% and the ChiNext Index declined by 0.23%. The STAR Market Composite Index advanced by 1.47%.
Sector-wise, the GPU segment led gains with a strong upward movement. The pharmaceutical, aviation, and semiconductor sectors also demonstrated active performance. In contrast, the oil and gas, coal, and lithium battery sectors were among the top decliners.
In Hong Kong markets, the Hang Seng Tech Index increased by 1.84%, with JD.com, Baidu, and Trip.com Group leading the gains.
Computing power chip stocks experienced volatile rises. The GPU sector showed notable strength, with computing power chip shares fluctuating upwards. MXene surged over 13%, Moore Threads gained more than 6%, and Cambricon saw an intraday increase exceeding 6%, achieving a turnover of 11.1 billion yuan. Other companies including SMIC, Hygon, and VeriSilicon also followed with gains.
The consumer electronics sector remained active, with foldable screen concept stocks showing unusual upward momentum. Aoni Electron hit the 20% daily limit, Furong Science and Technology reached the limit-up, while Sichuan Changhong, HIFIMAN, and Hisense Visual Technology also surged.
According to estimates from TrendForce, the foldable phone market may see Apple's entry as early as the second half of 2026. Leveraging its brand image and consumer anticipation, Apple is projected to capture nearly 20% market share in the foldable phone segment by 2026.
The pharmaceutical sector continued its strong performance, with Bright Gene Biomedical hitting the 20% daily limit. Zhejiang Hisun Pharmaceutical Co.,Ltd., Beijing SL Pharmaceutical, and Harbin Pharmaceutical Group among others also surged by the daily limit.
Regarding market developments, He Yaqiong, Director of the Consumer Goods Industry Department at the Ministry of Industry and Information Technology, stated during a State Council policy briefing on April 15 that the ministry is currently formulating the "15th Five-Year Plan" for the pharmaceutical industry. The next steps will focus on achieving "four accelerations" to ensure every patient has access to better, superior, and more affordable medications.
Additionally, the General Office of the State Council recently issued the "Several Opinions on Improving the Drug Price Formation Mechanism," emphasizing the need to fully leverage the market's decisive role in resource allocation while enhancing government functions. The document aims to effectively serve the construction of a unified national market in the pharmaceutical field, establish a market-oriented drug price formation mechanism, stimulate market vitality, promote fair competition, maintain market order, highlight clinical value and medication accessibility, support high-quality development of the pharmaceutical industry, and ensure people's access to quality, affordable medicines.
Comments